Compare
CVS Health vs Quest Diagnostics (CVS vs DGX)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year CVS Health (CVS) returned +6.8% and Quest Diagnostics (DGX) +43.4%; so far this year the figures are +5.7% and +47.3%.
CVS Health is the larger company by market value, about 3.8 times the size of Quest Diagnostics.
On trailing earnings, CVS trades at 9.7 times and DGX at 25.5 times.
Revenue grew +6.7% at CVS and +9.1% at DGX over the last year.
CVS yields 3.17%. DGX yields 1.32%.
Data as of the latest close. Not investment advice.
Relative performance
| CVS | DGX | |
|---|---|---|
| Price | $83.85 | $255.63 |
| 1-day | +3.10% | +0.35% |
| YTD | +5.66% | +47.31% |
| 1 year | +6.75% | +43.40% |
| 3 years | +22.00% | +92.88% |
| Market cap | $107.3B | $28.1B |
| P/E | 9.7 | 25.5 |
| P/S | 0.26 | 2.38 |
| P/B | 1.33 | 3.69 |
| Revenue growth | +6.70% | +9.10% |
| EPS growth | +2107.70% | +17.80% |
| Gross margin % | 44.2 | 33.1 |
| Net margin % | 2.6 | 9.5 |
| ROE % | 13.7 | 14.8 |
| Debt / equity | 0.75 | 0.73 |
| FCF yield % | 14.5 | 4.9 |
| Dividend yield % | 3.17 | 1.32 |
| Beta | -0.06 | -0.05 |
| RSI (14) | 39.9 | 66.9 |
| Technical rating |